167 related articles for article (PubMed ID: 31114984)
1. LncRNA SNHG7 participates in osteosarcoma progression by down-regulating p53 via binding to DNMT1.
Zhang GD; Gai PZ; Liao GY; Li Y
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3602-3610. PubMed ID: 31114984
[TBL] [Abstract][Full Text] [Related]
2. lncRNA HOXB-AS3 promotes hepatoma by inhibiting p53 expression.
Zhang XM; Chen H; Zhou B; Zhang QY; Liao Y; Wang JS; Wang ZH
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6784-6792. PubMed ID: 30402841
[TBL] [Abstract][Full Text] [Related]
3. LncRNA SNHG1 promotes liver cancer development through inhibiting p53 expression via binding to DNMT1.
Li SJ; Wang L; Sun ZX; Sun SJ; Gao J; Ma RL
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2768-2776. PubMed ID: 31002127
[TBL] [Abstract][Full Text] [Related]
4. LncRNA LINC00673 inhibits p53 expression by interacting with EZH2 and DNMT1 in papillary thyroid carcinoma.
Meng XF; Zhao LY; Chu XF
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2075-2083. PubMed ID: 30915752
[TBL] [Abstract][Full Text] [Related]
5. LINC01116 promotes proliferation, invasion and migration of osteosarcoma cells by silencing p53 and EZH2.
Zhang ZF; Xu HH; Hu WH; Hu TY; Wang XB
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6813-6823. PubMed ID: 31486480
[TBL] [Abstract][Full Text] [Related]
6. Long Noncoding RNA SNHG7 Promotes the Tumor Growth and Epithelial-to-Mesenchymal Transition via Regulation of miR-34a Signals in Osteosarcoma.
Deng Y; Zhao F; Zhang Z; Sun F; Wang M
Cancer Biother Radiopharm; 2018 Nov; 33(9):365-372. PubMed ID: 29989838
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA ATB participates in the development of renal cell carcinoma by downregulating p53 via binding to DNMT1.
Song C; Xiong Y; Liao W; Meng L; Yang S
J Cell Physiol; 2019 Aug; 234(8):12910-12917. PubMed ID: 30536843
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA GClnc1 promotes progression of colorectal cancer by inhibiting p53 signaling pathway.
Dong YX; Pang ZG; Zhang JC; Hu JQ; Wang LY
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5705-5713. PubMed ID: 31298323
[TBL] [Abstract][Full Text] [Related]
9. LncRNA SNHG7 promotes the proliferation and inhibits apoptosis of gastric cancer cells by repressing the P15 and P16 expression.
Wang MW; Liu J; Liu Q; Xu QH; Li TF; Jin S; Xia TS
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4613-4622. PubMed ID: 29131253
[TBL] [Abstract][Full Text] [Related]
10. FOXP4-AS1 participates in the development and progression of osteosarcoma by downregulating LATS1 via binding to LSD1 and EZH2.
Yang L; Ge D; Chen X; Qiu J; Yin Z; Zheng S; Jiang C
Biochem Biophys Res Commun; 2018 Aug; 502(4):493-500. PubMed ID: 29859193
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of long noncoding RNA SNHG7 inhibits the proliferation and promotes apoptosis of thyroid cancer cells by downregulating BDNF.
Wang YH; Huo BL; Li C; Ma G; Cao W
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4815-4821. PubMed ID: 31210313
[TBL] [Abstract][Full Text] [Related]
12. LncRNA SNHG7 promotes the proliferation of esophageal cancer cells and inhibits its apoptosis.
Xu LJ; Yu XJ; Wei B; Hui HX; Sun Y; Dai J; Chen XF
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2653-2661. PubMed ID: 29771415
[TBL] [Abstract][Full Text] [Related]
13. LncRNA LINC00628 overexpression inhibits the growth and invasion through regulating PI3K/Akt signaling pathway in osteosarcoma.
He R; Wu JX; Zhang Y; Che H; Yang L
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5857-5866. PubMed ID: 30280767
[TBL] [Abstract][Full Text] [Related]
14. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186.
Luo X; Song Y; Tang L; Sun DH; Ji DG
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7788-7797. PubMed ID: 30536320
[TBL] [Abstract][Full Text] [Related]
15. [LncRNA LINC-PINT regulating proliferation and apoptosis of osteosarcoma cells by targeting miR-524-5p].
Yang H; Cao C; Wang LJ
Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):325-330. PubMed ID: 32375449
[No Abstract] [Full Text] [Related]
16. LncRNA-SNHG7 regulates proliferation, apoptosis and invasion of bladder cancer cells assurance guidelines.
Zhong X; Long Z; Wu S; Xiao M; Hu W
J BUON; 2018; 23(3):776-781. PubMed ID: 30003751
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
18. Antidifferentiation Noncoding RNA Regulates the Proliferation of Osteosarcoma Cells.
Min L; Hong S; Duan H; Zhou Y; Zhang W; Luo Y; Shi R; Tu C
Cancer Biother Radiopharm; 2016 Mar; 31(2):52-7. PubMed ID: 26986815
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SAMD12-AS1 Promotes the Progression of Gastric Cancer via DNMT1/p53 Axis.
Lu GH; Zhao HM; Liu ZY; Cao Q; Shao RD; Sun G
Arch Med Res; 2021 Oct; 52(7):683-691. PubMed ID: 33962804
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA TUG1 contributes to tumorigenesis of human osteosarcoma by sponging miR-9-5p and regulating POU2F1 expression.
Xie CH; Cao YM; Huang Y; Shi QW; Guo JH; Fan ZW; Li JG; Chen BW; Wu BY
Tumour Biol; 2016 Nov; 37(11):15031-15041. PubMed ID: 27658774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
